201 related articles for article (PubMed ID: 21501103)
1. Incidence of gastrointestinal bleeding in patients with cardiovascular disease: buffered aspirin versus enteric-coated aspirin.
Hirata Y; Kataoka H; Shimura T; Mizushima T; Mizoshita T; Tanida S; Kamiya T; Joh T
Scand J Gastroenterol; 2011 Jul; 46(7-8):803-9. PubMed ID: 21501103
[TBL] [Abstract][Full Text] [Related]
2. Difference in risk of gastrointestinal complications between users of enteric-coated and buffered low-dose aspirin.
Takada M; Fujimoto M; Hosomi K
Int J Clin Pharmacol Ther; 2014 Mar; 52(3):181-91. PubMed ID: 24472400
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan.
Nadatani Y; Watanabe T; Tanigawa T; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Yoshiyama M; Arakawa T
Scand J Gastroenterol; 2013 Mar; 48(3):320-5. PubMed ID: 23298342
[TBL] [Abstract][Full Text] [Related]
4. Concomitant use of buffered and enteric-coated low-dose aspirin products and antisecretory drugs.
Takada M; Fukumoto K; Shibakawa M
J Clin Pharm Ther; 2004 Apr; 29(2):183-7. PubMed ID: 15068408
[TBL] [Abstract][Full Text] [Related]
5. Continuing or discontinuing low-dose aspirin before transrectal prostate biopsy: results of a prospective randomized trial.
Giannarini G; Mogorovich A; Valent F; Morelli G; De Maria M; Manassero F; Barbone F; Selli C
Urology; 2007 Sep; 70(3):501-5. PubMed ID: 17688919
[TBL] [Abstract][Full Text] [Related]
6. Difference between the frequencies of antisecretory drug prescriptions in users of buffered vs. enteric-coated low-dose aspirin therapies.
Hachiken H; Murai A; Wada K; Kuwahara T; Hosomi K; Takada M
Int J Clin Pharmacol Ther; 2013 Oct; 51(10):807-15. PubMed ID: 24040850
[TBL] [Abstract][Full Text] [Related]
7. Differences in the severity of small bowel mucosal injury based on the type of aspirin as evaluated by capsule endoscopy.
Endo H; Sakai E; Higurashi T; Yamada E; Ohkubo H; Iida H; Koide T; Yoneda M; Abe Y; Inamori M; Hosono K; Takahashi H; Kubota K; Nakajima A
Dig Liver Dis; 2012 Oct; 44(10):833-8. PubMed ID: 22749649
[TBL] [Abstract][Full Text] [Related]
8. Salicylate-induced gastrointestinal bleeding: comparison between soluble buffered, enteric-coated, and intravenous administration.
Mielants H; Verbruggen G; Schelstraete K; Veys EM
J Rheumatol; 1979; 6(2):210-8. PubMed ID: 313448
[TBL] [Abstract][Full Text] [Related]
9. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
10. Does enteric-coated aspirin result in a lower incidence of gastrointestinal complications compared to normal aspirin?
Walker J; Robinson J; Stewart J; Jacob S
Interact Cardiovasc Thorac Surg; 2007 Aug; 6(4):519-22. PubMed ID: 17669925
[TBL] [Abstract][Full Text] [Related]
11. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product.
Kelly JP; Kaufman DW; Jurgelon JM; Sheehan J; Koff RS; Shapiro S
Lancet; 1996 Nov; 348(9039):1413-6. PubMed ID: 8937281
[TBL] [Abstract][Full Text] [Related]
12. A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin.
Piazuelo E; Fuentes J; García-González MA; Jiménez P; Lanas A
Clin Ther; 2008 Jan; 30(1):121-30. PubMed ID: 18343248
[TBL] [Abstract][Full Text] [Related]
13. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin.
Sørensen HT; Mellemkjaer L; Blot WJ; Nielsen GL; Steffensen FH; McLaughlin JK; Olsen JH
Am J Gastroenterol; 2000 Sep; 95(9):2218-24. PubMed ID: 11007221
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal blood loss with low dose (325 mg) plain and enteric-coated aspirin administration.
Savon JJ; Allen ML; DiMarino AJ; Hermann GA; Krum RP
Am J Gastroenterol; 1995 Apr; 90(4):581-5. PubMed ID: 7717315
[TBL] [Abstract][Full Text] [Related]
15. Fecal hemoglobin excretion in elderly patients with atrial fibrillation: combined aspirin and low-dose warfarin vs conventional warfarin therapy.
Blackshear JL; Baker VS; Holland A; Litin SC; Ahlquist DA; Hart RG; Ellefson R; Koehler J
Arch Intern Med; 1996 Mar; 156(6):658-60. PubMed ID: 8629878
[TBL] [Abstract][Full Text] [Related]
16. Aspirin preparation and risk of GI bleeding.
Rao G
J Fam Pract; 1997 Mar; 44(3):242-3. PubMed ID: 9071237
[No Abstract] [Full Text] [Related]
17. Combination of low-dose aspirin and thienopyridine exacerbates small bowel injury.
Shiotani A; Honda K; Murao T; Ishii M; Fujita M; Matsumoto H; Tarumi K; Kamada T; Sakakibara T; Haruma K
Scand J Gastroenterol; 2011 Mar; 46(3):281-6. PubMed ID: 21133822
[TBL] [Abstract][Full Text] [Related]
18. Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study.
Rahme E; Bardou M; Dasgupta K; Toubouti Y; Ghosn J; Barkun AN
Rheumatology (Oxford); 2007 Feb; 46(2):265-72. PubMed ID: 16844699
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa.
Lanza FL; Royer GL; Nelson RS
N Engl J Med; 1980 Jul; 303(3):136-8. PubMed ID: 6966762
[No Abstract] [Full Text] [Related]
20. Proximal predominance of small bowel injury associated with uncoated low-dose aspirin therapy: a video capsule study in chronic users.
Ehrhard F; Nazeyrollas P; Brixi H; Heurgue-Berlot A; Thiéfin G
Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1265-72. PubMed ID: 23873021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
